Abstract:Tripartite motif (TRIM) 59 protein, a cancer-associated E3 ubiquitin ligase, plays important roles in various biological processes including innate immune response, autophagy, cell cycle, glycolysis and tumorigenicity. The mechanism of autophagy regulated by TRIM59 in non-small cell lung cancer (NSCLC) has been elucidated clearly. It has been demonstrated that TRIM59 was a novel molecule prognostic factor of NSCLC and frequently up-regulated in NSCLC patients, that was verified in The Cancer Genome Atlas (TCGA) datasets. Nevertheless, it still remains unclear of the correlation between TRIM59 expression and immune infiltrates as well as the predictive value of TRIM59 in lung adenocarcinoma (LUAD). In this study, analysis of TRIM59 expression in normal and tumor tissues indicated that TRIM59 was up-regulated in most tumor tissues based on RNA-seq datasets from TCGA and Genotype-Tissue Expression (GTEx) databases. The correlation analysis between TRIM59 expression and overall survival (OS), disease-specifical survival (DSS), disease-free interval (DFI) or progress free interval (PFI), suggested that high TRIM59 expression predicted adverse outcomes in LUAD (OS: P=0.00096; DSS: P=0.00056; DFI: P=0.0009; PFI: P=0.0012). The correlation analysis between TRIM59 and immune checkpoints revealed that TRIM59 was significantly correlated with most of immune checkpoints in TCGA database, and TRIM59 had significant correlation with TMB (P<0001), ESITIMATE score (P=0.04) or stromal score (P=0.005) in LUAD. Further investigation demonstrated that the significantly negative correlation between TRIM59 expression and tumor purity was only shown in LUAD (P=0.027). It was found that TRIM59 had significant correlation with gene markers on macrophage and neutrophil in Tumor Immune Estimation Resource (TIMER) database, indicating that TRIM59 expression in LUAD played an essential regulatory role in tumor immune progress including infiltration of macrophage and neutrophil. Functional enrichment analysis as well as correlation analysis between TRIM59 and clinical characteristics of LUAD patients was also performed in our report. Combined with previously reported prognostic role of TRIM59 in NSCLC, our results proved that TRIM59 is a prognosticator for LUAD and is correlated with immune infiltrates in LUAD. Funding Statement: This work was supported by the National Natural Science Foundation of China (81703072), The Natural Science Foundation of Zhejiang Province (LQ21H160027). Declaration of Interests: The authors have no conflict of interests.

TRIM67 interacts with ENAH to regulate the apoptosis and autophagy of lung cancer cells

Trim21 modulates endoplasmic reticulum-associated degradation and sensitizes cancer cells to ER stress-induced apoptosis by inhibiting VCP/Npl4/UFD1 assembly

High TRIM59 Expression Predicts Adverse Outcomes and is Correlated with Immune Infiltrates in Lung Adenocarcinoma

Integrated Bioinformatics Analysis Reveals Correlations of High TRIM59 Expression with Worse Prognosis and Immune Infiltrates in Lung Adenocarcinoma

TRIM37 targets AKT in the growth of lung cancer cells.

Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination

TRIM67 Promotes Non-Small Cell Lung Cancer Development by Positively Regulating the Notch Pathway through DLK1 Ubiquitination

TRIM67 Promotes NF‑κB Pathway and Cell Apoptosis in GA‑13315‑treated Lung Cancer Cells.

TRIM36 enhances lung adenocarcinoma radiosensitivity and inhibits tumorigenesis through promoting RAD51 ubiquitination and antagonizing hsa-miR-376a-5p

Tripartite Motif‐containing 37 (TRIM37) Promotes the Aggressiveness of Non‐small‐cell Lung Cancer Cells by Activating the NF‐κB Pathway

TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis

Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis Via Binding RAD50.

TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells

TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins

TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK/NF-κB/NLRP3 pathway

TRIM45 Suppresses the Development of Non-small Cell Lung Cancer.

TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling

TRIM47 Overexpression is a Poor Prognostic Factor and Contributes to Carcinogenesis in Non-Small Cell Lung Carcinoma

TRIM2 Directly Deubiquitinates and Stabilizes Snail1 Protein, Mediating Proliferation and Metastasis of Lung Adenocarcinoma

E3 Ubiquitin Ligase Tripartite Motif-Containing 71 Promotes the Proliferation of Non-Small Cell Lung Cancer Through the Inhibitor of Kappab-Α/nuclear Factor Kappab Pathway.

TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells Via Targeting MMP9